Cancer Science & Therapy

2^nd World Congress on Cancer Science & Therapy

September 10-12, 2012 Hilton San Antonio Airport, USA

Scientific Tracks Abstracts

• Prevention of Barrett’s Esophagus (BE) and Esophageal Adenocarcinoma (EAC) in the Levrat rat model of EAC by treatment with the smoothened (SMO) inhibitor

  Michael K. Gibson

  PDF HTML

• Glutamine drives glucose-independent TCA cycle

  Anne Le

  PDF HTML

• A new approach in the treatment of radiation-induced delayed brain injuries of NPC

  Yanqing Feng

  PDF HTML

• A new approach in the treatment of radiation-induced delayed brain injuries of NPC

  Yanqing Feng

  PDF HTML

• Mobile phones and cancer: Evaluation of the international agency for research on cancer

  Vijayalaxmi

  PDF HTML

• Exposure to heavy ion space radiation enhances risk of colorectal cancer in Apcmin/+ mouse model

  Kamal Datta

  PDF HTML

• Longitudinal monitoring of EGFR mutation and amplification status in circulating epithelial tumor cells (CETC) of lung cancer patients

  Pachmann Katharina, Abdollahi Amir, Schill Erika, Köhler Katrin, Brede-Hekimian Katya and Debus Jürgen

  PDF HTML

• Blood glutamate scavengers prolong the survival of rats and mice with brain-implanted gliomas

  Angela Ruban

  PDF HTML

• A metabonomic evaluation of the balkan endemic nephropathy

  Jean-Marie Colet

  PDF HTML

• Microarray analysis reveals salinomycin-induced apoptosis and activated endoplasmic reticulum stress of human prostate cancer PC-3 cells

  Soon-Cheol Ahn, Kwang-Youn Kim, Sun-Nyoung Yu, Sang-Hun Kim and Sung-Sik Chun

  PDF HTML

• Autophagy induced by 5-fluorouracil and hypoxia in CD133+ colon carcinoma cells maintain the cytoactive

  Min Li

  PDF HTML

• MicroRNAs as novel therapeutic adjuvants to treat drug resistant breast cancers

  Manjeet K Rao

  PDF HTML

• Safety and efficacy of non-pegylated liposomal doxorubicin (NPLD) at two different dose levels as compared to conventional doxorubicin in patients (pts) with metastatic breast cancer (MBC): A phase II/III open label mult

  R. H. Jani, D. D. Gambhire, G.V. Daftary, H. Panchal, M. Basade and C. Tamane

  PDF HTML

• Comparison of various strategies for colorectal cancer srceening tests

  Pavel Wohl1, Michal Bednarík2, Petr Wohl1, Milan Cervenka2, Drastich Pavel1 and Julius Špicák2

  PDF HTML

• Prolylcarboxypeptidase may contributes to the disease process of prostate cancer

  Zia Shariat-Madar

  PDF HTML

• Cancer stem cells and biological behavior of head and neck squamous cell cancer

  Stefania Staibano, Massimo Mascolo, Francesco Merolla and Gaetano de Rosa

  PDF HTML

• Induction of apoptosis in breast cancer cells MCF7 by K. foetidissima

  Lesetja Motadi

  PDF HTML

• Endogenous angioinhibitors from Type IV collagen and their mechanism(s) of action

  Sudhakar Akul Yakkanti

  PDF HTML

• Cystatins as inhibitors of metastatic disease

  James L. Cox

  PDF HTML

• Differential activation of signaling pathways in epithelial cells in response to cigarette smoking

  Li-Mei Chen

  PDF HTML

• Regulation of miR-483 locus in hepatocarcinoma cancer cells

  Angelo Veronese

  PDF HTML

• Death receptor mediates apoptosis activation by extracellular matrix molecule

  Raj Kumar Verma, Venugopal Gunda, Chandra Shekhar Boosani Smita C. Pawar and Sudhakar Akul Yakkanti

  PDF HTML

• Targeting selective chemosensitization of cancer by phytochemicals

  Rajendra Sharma, Abha Sharma and Sharda P. Singh

  PDF HTML

• Regulation of tumor growth and metastasis through inhibition of laminin-10 degradation by Col4(a6)NC1

  Venugopal Gunda, Raj Kumar Verma, Smita C. Pawar Chittibabu Guda and Sudhakar A. Yakkanti

  PDF HTML

• LETM1 as a novel target for warburg effects in human cancers

  Jongsun Park

  PDF HTML

• Functional characterization of extracellular matrix derived endogenous angioinhibitor molecule

  Smita C. Pawar, Chittibabu Guda and Sudhakar A. Yakkanti

  PDF HTML

• Transforming growth factor-beta receptor interacting protein 1 negatively regulates Ezrin-mediated cancer cell migration

  Fei Yan

  PDF HTML

• Redox-sensitive inhibition of Hsp90 disrupts the super-chaperone complex and attenuates pancreatic adenocarcinoma

  Chitra Mandal, S. Sarkar, D. Dutta, S.K Samanta, K. Bhattacharya and Chhabinath Mandal

  PDF HTML

• Long-term exposure to cigarette smoke extract induces hypomethylation in the RUNX3, H19, and IGF2 loci in cultured urothelial cells

  Karl X. Chai

  PDF HTML

• Exploiting anti-tumor immunity to overcome relapse and improve remission duration

  Lei L Chen

  PDF HTML

• HuR and doxorubicin: How an RNA binding protein is involved in drug resistance

  Alessandro Provenzani

  PDF HTML

• Infratentorial tuberculoma mimics tumor in immunocompetent adults: An analysis of 11 patients

  Yanqing Feng

  PDF HTML

• From in silico discovery to anti-cancer activity: Targeting the non-ATP binding site of C-Jun N-terminal Kinase

  Tamer S. Kaoud and Kevin N. Dalby

  PDF HTML

• Theranostic nanoparticles for personalized cancer therapy

  Lily Yang

  PDF HTML

• Chloroquine and its analogs: A new promise of an old drug in cancer therapy

  Hoyun Lee

  PDF HTML

• Endonuclease delivery as a new anti-cancer therapy

  Alexei G. Basnakian

  PDF HTML

• Moving forward with an immunotherapy for the prevention of breast cancer recurrence

  Thomas Kieber-Emmons

  PDF HTML

• Overcoming drug resistance in cancer through modulation of ROS

  Amit K. Maiti

  PDF HTML

• Cholesterol masking of carbohydrate tumour antigens blocks tumour immune recognition and sheds new light on statin-based antineoplastic benefit

  Clifford A. Lingwood, Anton Novak, Bo Ngan, Karen Chadwick and Neil Fleshner

  PDF HTML

• The anti-proliferative activity of IRF-1 depends on a phospho-dependent degradation switch

  Nicole Clarke

  PDF HTML

• The anti-proliferative activity of IRF-1 depends on a phospho-dependent degradation switch

  Nicole Clarke

  PDF HTML

• Derivative of antiviral agent and histone deacetylase inhibitor selectively targeting viral and non-viral associated malignancies

  Ada Rephaeli

  PDF HTML

• Enhancing low dose doxorubicin-induced MCA-fibrosarcoma killing through an immunomodulator-mediated natural killer activation

  Khalid Z. Matalka

  PDF HTML

• Toll-Like receptor 7 regulates pancreatic carcinogenesis

  Adeel Ur Rehman

  PDF HTML

• Refinement of the free radical theory of cancer: Dietary recommendations

  Homer S. Black

  PDF HTML

• Is it time to investigate radiation hormesis as a method of reducing cancer mortality?

  Mohan Doss

  PDF HTML

• Important chromatin modifiers in metastatic breast cancer

  Sandip K. Mishra

  PDF HTML

• Anticancer activity of 1,4-dihydropyridine derivatives

  R. Surendra kumar1 and A. Jamal Abd ul Nasser

  PDF HTML

• Transcriptional response of DNA repair genes to DNA damage in cancer cells

  Daekyu Sun

  PDF HTML

• Cybrid model to understand mitochondria-nuclear cross talk in cancer

  Benny Abraham Kaipparettu

  PDF HTML

• Monomers to nanoplatforms for tumor-imaging and phototherapy

  Ravindra K. Pandey

  PDF HTML

• Occupational cancer in Australia and challenges in diagnosis

  Le Jian

  PDF HTML

• MR imaging biomarker of cancer mitochondrial redox state

  Kejia Cai

  PDF HTML

• Comprehensive study of oral squamous cell carcinoma patients using blood samples and gene expression profiles

  Nobuo Kondoh, Eiji Takayama, Masako Kamiya, Harumi Kawaki and Masayuki Motohashi

  PDF HTML

• Label-free quantification of diagonostic biomarkers of microRNA’s using ligase-assisted sandwich hybridization on a DNA microarray

  Takashi Funatsu and Taro Ueno

  PDF HTML

• Microsatellite instability: A potential target for development of new cancer biomarkers

  Prakash. C Sharma

  PDF HTML

• Estrogen Receptor Beta Signaling: A Novel Therapeutic Target for Gliomas

  Ratna K Vadlamudi

  PDF HTML